What Researchers Did
Researchers investigated the potential of hyperbaric oxygen therapy as an adjunctive treatment for chronic refractory osteomyelitis, specifically in the foot.
What They Found
The study suggests hyperbaric oxygen therapy can serve as an adjunctive treatment for chronic refractory osteomyelitis when conventional therapies fail or show slow response. It emphasizes the importance of considering risk factors and costs when integrating hyperbaric oxygen with other treatment methods.
What This Means for Canadian Patients
For Canadian patients suffering from chronic osteomyelitis resistant to standard treatments, hyperbaric oxygen therapy may offer an additional treatment option. However, decisions to pursue this therapy should involve careful consideration of potential risks and associated costs.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A significant limitation is that this preliminary report does not provide specific patient outcomes, detailed methodology, or quantitative data.